Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL400291 | 0.95 | TBXAS1 (0.36) | TBXAS1 | |
| SCHEMBL8468382 | 0.91 | TBXAS1 (0.32) | TBXAS1 | |
| SCHEMBL1802295 | 0.90 | TBXAS1 (0.34) | TBXAS1 | |
| SCHEMBL8468384 | 0.89 | TET2 (0.31) | — | |
| SCHEMBL1803453 | 0.88 | TBXAS1 (0.35) | TBXAS1 | |
| SCHEMBL399741 | 0.86 | TBXAS1 (0.34) | TBXAS1 | |
| SCHEMBL8466016 | 0.86 | TBXAS1 (0.34) | TBXAS1 | |
| SCHEMBL2239507 | 0.85 | TBXAS1 (0.34) | TBXAS1 | |
| SCHEMBL402993 | 0.85 | TBXAS1 (0.34) | TBXAS1 | |
| SCHEMBL7754184 | 0.85 | ABCC4 (0.34) | TBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3824005-B1 | LIQUID WOUND DRESSING COMPOSITION | USTAV MAKROMOLEKULARNI CHEMIE AV CR V V I (CZ) | 2023-02-22 | — | — | EP | claimed |
| EP-3660545-B9 | SILICONE HYDROGEL COMPOSITION, SILICONE HYDROGEL LENS, AND METHOD OF MANUFACTURING SILICONE HYDROGEL LENS | PEGAVISION CORP (TW) | 2021-12-29 | — | — | EP | claimed |
| EP-3660545-B1 | SILICONE HYDROGEL COMPOSITION, SILICONE HYDROGEL LENS, AND METHOD OF MANUFACTURING SILICONE HYDROGEL LENS | PEGAVISION CORP (TW) | 2021-06-16 | — | — | EP | claimed |
| US-20210171688-A1 | BIOCOMPATIBLE COPOLYMER, CURABLE COMPOSITION, BIOCOMPATIBLE COATING LAYER AND BIOCOMPATIBLE DEVICE INCLUDING THE SAME | NATIONAL CENTRAL UNIVERSITY (TW) | 2021-06-10 | — | — | US | claimed |
| EP-3220741-B1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | ROCHAL IND LLC (US) | 2021-02-24 | — | — | EP | claimed |
| EP-3052140-B1 | NON-SELF-ADHERENT COATING MATERIALS | ROCHAL IND LLC (US) | 2019-05-01 | — | — | EP | claimed |
| EP-1176454-B1 | OCULAR LENS MATERIALS AND PROCESS FOR PRODUCING THE SAME | MENICON CO LTD (JP) | 2003-07-30 | — | — | EP | claimed |
| EP-0796723-B1 | PROCESS FOR PRODUCING OPTIC LENS AND OPTIC LENS OBTAINED THEREBY | MENICON CO LTD (JP) | 2001-12-05 | — | — | EP | claimed |
| US-5883152-A | HARD CONTACT LENS CONSISTING OF A COPOLYMER OF CARBOXYLIC ACID ESTER MONOMER, TRIS(TRIMETHYLSILOXY)SILYLPROPYL(METH)ACRYLATE, AND COPOLYMERIZABLE MONOMER | NIPPON OIL AND FATS CO., LTD. (JP) | 1999-03-16 | — | — | US | claimed |
| US-20210171688-A1 | BIOCOMPATIBLE COPOLYMER, CURABLE COMPOSITION, BIOCOMPATIBLE COATING LAYER AND BIOCOMPATIBLE DEVICE INCLUDING THE SAME | NATIONAL CENTRAL UNIVERSITY (TW) | 2021-06-10 | — | — | US | disclosed |
| US-8662663-B2 | Hybrid soft contact lens, and production method and hydration treatment method thereof | MENICON CO., LTD. (JP) | 2014-03-04 | — | — | US | disclosed |
| US-8101701-B2 | having a hydrophilic group and a silicon-containing alkyl group within molecule; lenses with high oxygen permeability independent from the water content may be obtained, wherein the fumaric acid derivatives is superior in compatibility with the hydrophilic monomer used in combination | MENICON NECT CO., LTD. (JP) | 2012-01-24 | — | — | US | disclosed |
| US-20080132666-A1 | Fumaric Acid Derivatives and Ophthalmic Lenses Using the Same | MENICON NECT CO., LTD. (JP) | 2008-06-05 | — | — | US | disclosed |
| EP-1378769-A2 | Water-absorptive contact lens and method of producing the same | Menicon Co., Ltd. (JP) | 2004-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132666-A1 | Fumaric Acid Derivatives and Ophthalmic Lenses Using the Same | FAH, FH, AQP4 | TBXAS1 2741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.